Genomic analysis of mako shark reveals genes relating to tumor suppression in humans

December 01, 2020

Anecdotal reports claim that the incidence of cancer in sharks is very low, but there is not enough data to confirm this estimate categorically. A study published in the journal Genomics, however, presents strong evidence of anti-tumor activity in the genome of the Shortfin mako shark, Isurus oxyrinchus.

This large pelagic species, which can be as long as 4 meters, inhabits temperate and tropical seas worldwide. It is classified as endangered by IUCN, owing mainly to non-selective longline fishing with hundreds of hooks by factory ships that capture many animals in a single pass. They spend up to two months at sea, bringing back hundreds or even thousands of tons of fish.

Fishery observers with the Portuguese Institute for Sea and Atmosphere (IPMA) collected tissue samples of various organs from four mako sharks on one of these ships. Brazilian researchers genetically sequenced eye and liver tissue samples, finding that nine out of the ten most overexpressed genes in the animal's liver relate to tumor suppression in humans.

"Because these fishing cruises stay out at sea for such a long time, few of the tissue samples had well-conserved RNA. We managed to retrieve genetic material only from four livers and three eyes, but even so they produced surprising results," said
Rodrigo Domingues, first author of the paper. The study was conducted while Domingues was on a postdoctoral internship at the Federal University of São Paulo (UNIFESP) in its Department of Marine Sciences in Santos, Brazil, under the supervision of Fernando Mendonça.

Domingues performed part of the analysis while he was an intern at the Interdisciplinary Center of Marine and Environmental Research (CIIMAR) in Portugal, also with a scholarship from FAPESP (São Paulo Research Foundation). The research is part of a project involving Brazil-Portugal collaboration, funded by FAPESP and Portugal's Foundation for Science and Technology (FCT).

The analysis revealed 3,774 differentially expressed genes in the two organs - 1,612 in the eye and 2,162 in the liver. Most of the genes that were overexpressed in the eye related to the structure of the organ and visual signaling to the brain. Few genes relating to light reception were found, suggesting that the mako probably has monochrome vision and can see only shades of the same color, like all other sharks known to science.

The recently completed genome sequencing of the Great white shark (Carcharodon carcharias), the largest sequencing of any shark species, revealed two positively selected genes with anti-tumor activity. Hence the Brazilian researchers' surprise on finding that out of the top ten overexpressed genes in the mako's genome, no fewer than nine are cancer-related.

From colon cancer to glioma

Among the genes with above-normal activity in the liver, HABP2 is known to reduce colony formation and cellular migration in thyroid tumors, while PON3 encodes an enzyme that can act as a cellular antioxidant, protecting cells from oxidative stress, which is a significant factor in cancer.

NIT2, RMC1 and FGFRK1 are expressed in various tissues and are potential tumor suppressants. The first two relate to suppression of colon cancer cells, while the third has a negative effect on cell proliferation in the initiation and progression of prostate cancer.

ITIH3 is involved in inflammatory diseases, schizophrenia, depression, heart attack, and stomach cancer. CBS and A1CF are involved in the progression of colon, ovarian, and breast cancer, although CBS has tumor-suppressant effects in glioma, a common type of brain cancer. SERPIND1 plays a role in rapid wound healing in sharks, and in inflammation, blood clotting, and cancer metastasis in humans.

"To find out if any compounds from shark livers could act on human cells, we would need to make an extract from the organ and test it on tumor cells. If such bioactive compounds were found to produce a significant benefit, other groups could synthesize them and possibly use them to produce a new drug for therapeutic use," Domingues said.

The authors note that the mako is already being overfished by commercial fleets, which sell its fins to Asian markets and its meat in Brazil. "We, therefore, discourage increased fishing of the species and a further population decline for this additional purpose. On the other hand, it might be possible to combine research activities in order to optimize the sampling of this endangered shark species, especially when scientific observers are on commercial vessels and can continue to take samples from specimens that are already dead when captured," they write.

To contribute to the conservation of the species, the researchers are now looking for single nucleotide polymorphisms (SNPs), which can act as biological markers to locate mutations and help explain whether there are several population groups in this or that ocean, for example. If differences are found in certain regions of the genome in 200 samples from the Atlantic and Indian Oceans, it may be possible to use them to identify oceanographic factors (water temperature and salinity, chlorophyll levels etc.) that contribute to this separation into groups. If so, the information can be used to formulate fishery policy, including a ban on shark fishing in certain areas.
-end-
About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at http://www.fapesp.br/en and visit FAPESP news agency at http://www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.

Fundação de Amparo à Pesquisa do Estado de São Paulo

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.